维普中文期刊产品整合服务
18篇 您的检索式:作者名="Slobod KS"
    题名 作者 年代 出处 被引量
1Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients 显示文摘Heslop HE Slobod KS Pule MA 2010Blood2010,115,5:1
2Long- term outcome of EBV-specific T-cell infusions to prevent of treat EBV-related lymphoproliferative disease in transplant recipients 显示文摘lteslop HE Slobod KS Pule MA 2010Blood2010,115,5:1
3Long-term outcome ofEBV-specific T-cell infusions to prevent or treat EBV-relatedlymphoproliferative disease in transplant recipients 显示文摘Heslop HE Slobod KS Pule MA 2010Blood2010,115,:1
4Long-term outcome of specific T-cell infusions to prevent or treat EBV-related lymphopro- liferative disease in transplant recipients 显示文摘Heslop HE Slobod KS Pule MA 2010Blood2010,115,5:1
5Long-termout-come of EBV-specific T cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant re-cipients显示文摘Heslop HE Slobod KS Pule MA 2010Blood2010,115,5:1
6Preclinical and clinical de- velopment of a multi-envelope, DNA-virus-protein (D-V-P) HIV- 1 vaccine 显示文摘Sealy R Slobod KS Flynn P 2009Int Rev Immunol2009,28,1:1
7Profound abnormality of the B/T lymphocyte radio during chemotherapy for pediatric acute lympoblastie leukemia 显示文摘Caver TE Slobod KS Flynn PM 1998Leukemia1998,12,4:1
8Safety and immunogenicity of intranasal murine parainfluenza vires type 1 (Sendal rims) in healthy human adults 显示文摘Slobod KS Shenep JL Lujan-Zilbermann J 2004Vaccine2004,22,2324:1
9Long-term outcome of EBV- specific T-ceU infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients 显示文摘Heslop HE Slobod KS Pule MA 2010Blood2010,115,5:1
10Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells显示文摘Dave VP Allan JE Slobod KS 1994Virology1994,199,2:1
11Safety and immunoge-nicity of intranasal murine parainfluenza vires type 1 (Sendai vires) in healthy human adults 显示文摘Slobod KS Shenep JL Lujan-Zilbermann J 2004Vaccine2004,22,2324:1
12Safety and immunoge nicity of intranasal murine parainfluenza virus typel (sendai virus) in healthy human adults 显示文摘Slobod KS Shenep JL Lujáln-Zilbermann J 2004Vaccine2004,22,2324:1
13Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients显示文摘Heslop HE Slobod KS Pule MA 2010Blood2010,115,5:1
14Safety and immunogenicity of intranasal murine parainfluenza virus type I (Sendal virus) in healthy human adults 显示文摘Slobod KS Shenep JL Luidn-Zilbermann J 2004Vaccine2004,22,2324:1
15Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells显示文摘Dave VP Allan JE Slobod KS 1994Virology1994,199,2:1
16Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lyphoproliferative disease in transplant recipients显示文摘Heslop HE Slobod KS Pule MA 2010Blood2010,115,:1
17Long-term outcome of EBV-specific T cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients 显示文摘Heslop HE Slobod KS Pule MA 2010Blood2010,115,5:1
18Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients显示文摘Heslop HE Slobod KS Pule MA Hale GA Rousseau A Smith CA 2010Blood2010,115,5:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费